CID 3034010

Orlistat

Structural Information

Molecular Formula
C29H53NO5
SMILES
CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
InChI
InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1
InChIKey
AHLBNYSZXLDEJQ-FWEHEUNISA-N
Compound name
[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
Related CIDs

2D Structure

compound 2d structure
8
Annotation Hits

2155
References

79423
Patents

495.39236 Da
Monoisotopic Mass

10.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 496.39964 241.1
[M+Na]+ 518.38158 236.5
[M-H]- 494.38508 226.3
[M+NH4]+ 513.42618 236.8
[M+K]+ 534.35552 237.8
[M+H-H2O]+ 478.38962 225.8
[M+HCOO]- 540.39056 240.1
[M+CH3COO]- 554.40621 252.0
[M+Na-2H]- 516.36703 230.2
[M]+ 495.39181 230.2
[M]- 495.39291 230.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe